Benzinga | Nov 10, 2021 07:17AM EST

PDS Biotechnology Q3 EPS $(0.24) Misses $(0.20) Estimate

PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.20) by 20 percent. This is a 4.35 percent decrease over losses of $(0.23) per share from the same period last year.